Crenessity 50 mg/1
crinecerfont · CAPSULE · Neurocrine Biosciences, Inc.
Crenessity is a capsule containing crinecerfont at 50 mg/1, taken oral. Manufactured by Neurocrine Biosciences, Inc..
Key Facts
- Brand Name
- Crenessity
- Generic Name
- crinecerfont
- NDC Code (Product)
70370-5050- Manufacturer
- Neurocrine Biosciences, Inc.
- Strength
- 50 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA218808
- Drug Class
- Corticotropin-releasing Factor Type 1 Receptor Antagonist [EPC]
- Marketing Start
- 12/13/2024
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Crenessity used for?
Crenessity contains crinecerfont. It is a capsule taken oral. Consult your doctor for specific uses.
Is Crenessity a controlled substance?
Crenessity is not classified as a controlled substance by the DEA.
What is the generic name for Crenessity?
The generic name for Crenessity is crinecerfont. There are no other listed brand versions of crinecerfont.
What is the NDC code for Crenessity 50 mg/1?
The NDC (National Drug Code) for Crenessity 50 mg/1 is 70370-5050, listed by Neurocrine Biosciences, Inc..
Other Crenessity Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)